Use access key #2 to skip to page content.

February 2009

Recs

24

A question from an Idiot about the S&P comparison

February 23, 2009 – Comments (14)

I'm not sure it's good to be a Fool these days, so I'll refer to myself as an Idiot when asking this question I'm sure has been asked and answered many times.  [more]

Recs

21

Efficient market? Not in Biotech.

February 17, 2009 – Comments (6) | RELATED TICKERS: PGNX , LJPC

The central purpose of my concentration on the small-cap biotech sector is to disprove the hypothesis that the market cannot be beaten, i.e. that at any given moment the price of a stock closely reflects the weighted average of all possible outcomes for the company given all information publicly available. Needless to say, to accept this efficient market hypothesis is to render retail investing useless, as the laws of probability dictate an eventual zero sum game minus the costs of trading.  [more]

Featured Broker Partners


Advertisement